PMID- 27891557 OWN - NLM STAT- MEDLINE DCOM- 20180713 LR - 20181202 IS - 1573-6830 (Electronic) IS - 0272-4340 (Linking) VI - 37 IP - 7 DP - 2017 Oct TI - Exogenous Expression of Nt-3 and TrkC Genes in Bone Marrow Stromal Cells Elevated the Survival Rate of the Cells in the Course of Neural Differentiation. PG - 1187-1194 LID - 10.1007/s10571-016-0448-y [doi] AB - Bone marrow stromal cells (BMSCs) are attractive cellular sources for cell therapy of many diseases, specifically neurodegenerative ones. The potential capability of BMSCs could be further augmented by enhancing their neuroprotective property, differentiation potential, and survival rate subsequent to transplantation. Therefore, a concurrent upregulation of neurotrophin-3 (NT-3) and its high affinity receptor, tyrosin kinase C (TrkC), was utilized in our study. BMSCs were cotransfected with pDsRed1-N1-NT-3 and pCMX-TrkC plasmids before induction of neural differentiation. pEGFP-N1-transfected BMSCs were also employed as a control. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was employed for gene expression analysis. Cell viability was evaluated by MTT assay, while apoptosis rate was assessed by flow cytometry after PI and Annexin V staining. NT-3 and TrkC mRNA levels were greatly elevated following cotransfection of cells with pDsRed1-N1-NT-3 and pCMX-TrkC vectors. The expression of neural markers (i.e., NFM, and NeuroD1) was augmented in cotransfected BMSCs, compared to the control ones, after neural induction. At each time point, the viability and apoptosis rates of the cells over-expressing NT-3 and TrkC showed increased and reduced patterns, respectively. Our data demonstrated that NT-3/TrkC-co-transfected BMSCs, compared to those of intact cells, could be more beneficial graft candidates for the upcoming treatment strategies of neurogenic disorders due to their increased viability and expression of neural markers. This may be due to their increased level of neural differentiation potential and/or their enhanced rate of survival and/or their useful capacity to secrete NT-3. FAU - Edalat, Houri AU - Edalat H AD - Genetic Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. FAU - Hajebrahimi, Zahra AU - Hajebrahimi Z AD - Department of Physiology, Aerospace Research Institute, Tehran, Iran. FAU - Pirhajati, Vahid AU - Pirhajati V AD - Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. FAU - Tavallaei, Mahmoud AU - Tavallaei M AD - Genetic Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. FAU - Movahedin, Mansoureh AU - Movahedin M AD - Department of Anatomy, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran. FAU - Mowla, Seyed Javad AU - Mowla SJ AD - Department of Molecular Genetics, School of Biological Sciences, Tarbiat Modares University, Tehran, Iran. sjmowla@modares.ac.ir. LA - eng GR - 3657/Basij Elmi Organization/ PT - Journal Article DEP - 20161128 PL - United States TA - Cell Mol Neurobiol JT - Cellular and molecular neurobiology JID - 8200709 RN - 0 (Neurotrophin 3) RN - EC 2.7.10.1 (Receptor, trkC) SB - IM MH - Animals MH - Cell Differentiation/*physiology MH - Cell Survival/physiology MH - Cells, Cultured MH - Gene Expression MH - Mesenchymal Stem Cells/*metabolism MH - Neurons/*metabolism MH - Neurotrophin 3/*biosynthesis/genetics MH - Rats MH - Rats, Sprague-Dawley MH - Receptor, trkC/*biosynthesis/genetics OTO - NOTNLM OT - Apoptosis OT - Bone marrow stromal cells OT - Cell viability OT - NT-3 OT - Neural differentiation OT - TrkC EDAT- 2016/11/29 06:00 MHDA- 2018/07/14 06:00 CRDT- 2016/11/29 06:00 PHST- 2016/01/20 00:00 [received] PHST- 2016/05/04 00:00 [accepted] PHST- 2016/11/29 06:00 [pubmed] PHST- 2018/07/14 06:00 [medline] PHST- 2016/11/29 06:00 [entrez] AID - 10.1007/s10571-016-0448-y [pii] AID - 10.1007/s10571-016-0448-y [doi] PST - ppublish SO - Cell Mol Neurobiol. 2017 Oct;37(7):1187-1194. doi: 10.1007/s10571-016-0448-y. Epub 2016 Nov 28.